First, gain-of-function and loss-of-function experiments should be conducted on SASH1 in HNSCC cells and animal models using CRISPR/Cas9 gene-editing technology to directly verify its effects on tumor proliferation, invasion, and matrix remodeling. The gene discussed is SASH1; the disease is neoplasm.